Technical

Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.


Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.